[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase II clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 for the treatment of primary sclerosing cholangitis, and GRI-0729, which are in pre-clinical development. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 53, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 64, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 59, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.21, "open": 1.2, "dayLow": 1.16, "dayHigh": 1.37, "regularMarketPreviousClose": 1.21, "regularMarketOpen": 1.2, "regularMarketDayLow": 1.16, "regularMarketDayHigh": 1.37, "payoutRatio": 0.0, "forwardPE": -0.5057034, "volume": 118990, "regularMarketVolume": 118990, "averageVolume": 292344, "averageVolume10days": 1754930, "averageDailyVolume10Day": 1754930, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 967386, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 130.39, "fiftyDayAverage": 6.37584, "twoHundredDayAverage": 11.76421, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4115709, "profitMargins": 0.0, "floatShares": 524754, "sharesOutstanding": 727358, "sharesShort": 19433, "sharesShortPriorMonth": 23782, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.037, "heldPercentInsiders": 0.00090000004, "heldPercentInstitutions": 0.02506, "shortRatio": 1.46, "shortPercentOfFloat": 0.038599998, "impliedSharesOutstanding": 788774, "bookValue": 7.673, "priceToBook": 0.17333508, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -10118000, "trailingEps": -55.19, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.5, "52WeekChange": -0.9886451, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 1.33, "targetHighPrice": 221.0001, "targetLowPrice": 170.00009, "targetMeanPrice": 195.5001, "targetMedianPrice": 195.5001, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5028000, "totalCashPerShare": 9.571, "ebitda": -8231000, "totalDebt": 119000, "quickRatio": 3.073, "currentRatio": 3.432, "debtToEquity": 2.951, "returnOnAssets": -1.18387, "returnOnEquity": -3.82522, "freeCashflow": -5550875, "operatingCashflow": -8611000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.33, "postMarketChange": 0.0, "regularMarketChange": 0.120000005, "regularMarketDayRange": "1.16 - 1.37", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 292344, "fiftyTwoWeekLowChange": 0.23000002, "fiftyTwoWeekLowChangePercent": 0.20909092, "fiftyTwoWeekRange": "1.1 - 130.39", "fiftyTwoWeekHighChange": -129.06, "fiftyTwoWeekHighChangePercent": -0.9897998, "corporateActions": [], "postMarketTime": 1744414985, "regularMarketTime": 1744401600, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 9.917356, "regularMarketPrice": 1.33, "marketState": "CLOSED", "fiftyTwoWeekChangePercent": -98.86451, "earningsTimestamp": 1742213100, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -55.19, "epsForward": -2.63, "epsCurrentYear": -15.72501, "priceEpsCurrentYear": -0.08457865, "fiftyDayAverageChange": -5.0458403, "fiftyDayAverageChangePercent": -0.7914001, "twoHundredDayAverageChange": -10.43421, "twoHundredDayAverageChangePercent": -0.88694525, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]